COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Qualitative Test, version 2.0
- UID
- IMP/MD/2018/000210_1007715bcdd645c240fa7be27b27bb5f_c56d3722d8014cca97e47254f90ec126
- Device class
- Class D
- Brand name
- cobas® HCV
- License holder
- Roche Diagnostics India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Qualitative Test, version 2.0 is an in vitro diagnostic, total nucleic acid amplification test for the qualitative detection of Human Immunodeficiency Virus Type 1 (cobas® HCV) DNA and RNA (cobas® HCV) in human plasma or dried blood spots using the COBAS® AmpliPrep Instrument for automated specimen processing and the COBAS® TaqMan® Analyzer or COBAS® TaqMan® 48 Analyzer for automated amplification and detection. The test is a diagnostic test, indicated for individuals who are suspected to be actively infected with HIV-1. Detection of HIV-1 TNA is indicative of active HIV infection. Infants born to mothers infected with HIV-1 may have maternal antibodies to HIV-1, and the presence of HIV-1 nucleic acid in the infant indicates active HIV-1 infection. In adults, the test may be used as an aid in the diagnosis of HIV-1 infection.
COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Qualitative Test, version 2.0 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000210_1007715bcdd645c240fa7be27b27bb5f_c56d3722d8014cca97e47254f90ec126. This device is marketed under the brand name cobas® HCV. The license holder is Roche Diagnostics India Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.